Home » Topics » Disease categories and therapies » Infection

Infection
RSS

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Advisory panel recommends approval of Synercid

Feb. 20, 1998

Glaxo Wellcome enrolls patients in phase III flu drug trials

Feb. 20, 1998

Shionogi investigates new cephem compounds

Feb. 19, 1998

KY-62 evaluated in murine models of candidiasis

Feb. 18, 1998

Cubist outlines development plans for daptomycin

Feb. 18, 1998

SKB and WHO join forces to wipe out lymphatic filariasis

Feb. 18, 1998

Patients sought for GS-4104 clinical study

Feb. 17, 1998

Amphocil marketing agreement signed for Mexico

Feb. 16, 1998

Imiquimod for selftreatment of external anogenital warts

Feb. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...